About Shanmuga Hospital Ltd
Shanmuga Hospital is engaged in the business of establishing, maintaining, assisting, encouraging or promoting in India, as and when deemed proper or expedient for the purpose of medical relief, in the form of hospitals, institutions or in connection therewith or attached thereto all or any of the following institutions: Nursing Homes, Hospitals, Multispeciality Hospitals or Wards, rehabilitation centers, I.C.U.s, I.C.C.U.s and related units, Diagnostic Centers, Scan Center, Health centers and other related centers, Physiotherapy, Laboratories, Dispensaries, Blood bank and Creches.
Founded
2020
CEO
Prabu Sankar Panneerselvam
Employees
242
HQ
Salem, Tamil Nadu
Finished Products
1Sale of Services
₹116.90Cr2Sale of Goods
₹13.34CrRaw Materials
1Medicines & Consumables
₹33.87CrAbout Shanmuga Hospital Ltd
Shanmuga Hospital is engaged in the business of establishing, maintaining, assisting, encouraging or promoting in India, as and when deemed proper or expedient for the purpose of medical relief, in the form of hospitals, institutions or in connection therewith or attached thereto all or any of the following institutions: Nursing Homes, Hospitals, Multispeciality Hospitals or Wards, rehabilitation centers, I.C.U.s, I.C.C.U.s and related units, Diagnostic Centers, Scan Center, Health centers and other related centers, Physiotherapy, Laboratories, Dispensaries, Blood bank and Creches.
Founded:2020
CEO:Prabu Sankar Panneerselvam
Employees:242
HQ:Salem, Tamil Nadu
Finished Products
1Sale of Services
₹116.90Cr2Sale of Goods
₹13.34CrRaw Materials
1Medicines & Consumables
₹33.87CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹57
52W Low
₹34
Volume8.00K
Avg VolumeN/A
Beta0.81
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
13.14x
Valuation
P/B Ratio
1.31x
Valuation
EPS
₹3.12
Valuation
Dividend Yield
0.00%
Valuation
ROE
9.91%
Profitability
ROCE
12.37%
Profitability
Revenue by Segment
Contribution & growth by business line
Sale of medicines and services to tRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.16x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.